News
Michelle Kloese, 42, lost weight and kept it off through simple habits: walking, water-intake logging, and meal swaps.
We’ve all struggled with losing weight—starting over, giving up, feeling stuck. Harshda Ambavane, a 39-year-old yoga teacher, ...
A new daily weight-loss pill could be just as effective as the popular injectables that help patients lower their blood sugar and lose unwanted weight. "I think we're really at the beginning of a ...
The successful trial of a daily weight-loss pill has been hailed as a “landmark moment” in the fight against obesity, with Ireland’s leading expert in the field describing it as a “huge ...
The success of GLP-1 weight loss injectable drugs – Ozempic, the GLP-1 diabetes shot from Novo Nordisk, and Eli Lilly’s weight loss treatment Zepbound and diabetes drug Mounjaro – has set ...
FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...
announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss. The trial of the drug ...
Lizzo is feelin’ good as hell in her new lace. The Yitty co-founder, who’s been publicly documenting her fitness journey, showed another look at her weight transformation by modeling her ...
The drugs are GLP-1 medications, taken as a weekly injection, which help with weight loss and blood sugar management in people who have type 2 diabetes. GLP-1 drugs increase the levels of ...
Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
The former Playboy model, who dated the late Hugh Hefner, shared that she began taking an injectable weight loss drug—though she didn’t stick to it for long. “I started the weight loss shots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results